Log in

NYSE:LTHMLivent Stock Price, Forecast & News

$7.09
+0.23 (+3.35 %)
(As of 08/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$6.44
Now: $7.09
$7.09
50-Day Range
$5.74
MA: $6.52
$7.80
52-Week Range
$3.95
Now: $7.09
$12.29
Volume2.89 million shs
Average Volume2.74 million shs
Market Capitalization$1.04 billion
P/E Ratio32.23
Dividend YieldN/A
Beta2.03
Livent Corporation manufactures and sells performance lithium compounds that are used primarily in energy storage, specialty polymers, and chemical synthesis application. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and supplies butyllithium, which is used as a synthesizer in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries. Livent Corporation was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 1.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.18 out of 5 stars


Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone215-299-6000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$388.40 million
Cash Flow$0.56 per share
Book Value$3.73 per share

Profitability

Net Income$50.20 million

Miscellaneous

EmployeesN/A
Market Cap$1.04 billion
Next Earnings DateN/A
OptionableNot Optionable
$7.09
+0.23 (+3.35 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LTHM News and Ratings via Email

Sign-up to receive the latest news and ratings for LTHM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Livent (NYSE:LTHM) Frequently Asked Questions

How has Livent's stock been impacted by COVID-19 (Coronavirus)?

Livent's stock was trading at $7.47 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, LTHM stock has decreased by 5.1% and is now trading at $7.09.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Livent?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Livent in the last year. There are currently 1 sell rating, 7 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Livent
.

How were Livent's earnings last quarter?

Livent Corporation (NYSE:LTHM) announced its quarterly earnings results on Thursday, August, 6th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by $0.03. The company earned $64.90 million during the quarter, compared to the consensus estimate of $76.23 million. Livent had a return on equity of 8.52% and a net margin of 8.76%. The firm's quarterly revenue was down 43.1% compared to the same quarter last year. During the same quarter last year, the company posted $0.12 earnings per share.
View Livent's earnings history
.

What price target have analysts set for LTHM?

9 analysts have issued 12-month price targets for Livent's shares. Their forecasts range from $5.00 to $8.00. On average, they anticipate Livent's stock price to reach $6.25 in the next year. This suggests that the stock has a possible downside of 11.8%.
View analysts' price targets for Livent
.

Has Livent been receiving favorable news coverage?

Media coverage about LTHM stock has been trending very positive this week, according to InfoTrie. The research firm rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Livent earned a coverage optimism score of 4.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future.
View the latest news about Livent
.

Are investors shorting Livent?

Livent saw a increase in short interest in the month of July. As of July 31st, there was short interest totaling 23,620,000 shares, an increase of 10.3% from the July 15th total of 21,420,000 shares. Based on an average daily volume of 2,650,000 shares, the days-to-cover ratio is presently 8.9 days. Currently, 16.3% of the shares of the stock are sold short.
View Livent's Current Options Chain
.

Who are some of Livent's key competitors?

What other stocks do shareholders of Livent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Livent investors own include Albemarle (ALB), Walt Disney (DIS), Alibaba Group (BABA), AT&T (T), Northrop Grumman (NOC), NVIDIA (NVDA), AbbVie (ABBV), Freeport-McMoRan (FCX), CVS Health (CVS) and General Electric (GE).

When did Livent IPO?

(LTHM) raised $380 million in an IPO on Thursday, October 11th 2018. The company issued 20,000,000 shares at a price of $18.00-$20.00 per share. BofA Merrill Lynch, Goldman Sach and Credit Suisse served as the underwriters for the IPO and Citigroup, Loop Capital Markets and Nomura were co-managers.

What is Livent's stock symbol?

Livent trades on the New York Stock Exchange (NYSE) under the ticker symbol "LTHM."

Who are Livent's major shareholders?

Livent's stock is owned by a number of retail and institutional investors. Top institutional investors include Ruffer LLP (1.91%), Robecosam AG (0.89%), Granite Investment Partners LLC (0.88%), Principal Financial Group Inc. (0.76%), Peregrine Capital Management LLC (0.50%) and Capital Management Corp VA (0.29%). Company insiders that own Livent stock include Nicholas Pfeiffer and Steven T Merkt.
View institutional ownership trends for Livent
.

Which institutional investors are selling Livent stock?

LTHM stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, Robecosam AG, First Trust Advisors LP, Principal Financial Group Inc., Texas Permanent School Fund, Royal London Asset Management Ltd., Regent Investment Management LLC, and Brinker Capital Inc..
View insider buying and selling activity for Livent
.

Which institutional investors are buying Livent stock?

LTHM stock was bought by a variety of institutional investors in the last quarter, including Ruffer LLP, Hussman Strategic Advisors Inc., Capital Management Corp VA, Canal Insurance CO, FNY Investment Advisers LLC, Ingalls & Snyder LLC, Swiss National Bank, and Trexquant Investment LP. Company insiders that have bought Livent stock in the last two years include Nicholas Pfeiffer, and Steven T Merkt.
View insider buying and selling activity for Livent
.

How do I buy shares of Livent?

Shares of LTHM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Livent's stock price today?

One share of LTHM stock can currently be purchased for approximately $7.09.

How big of a company is Livent?

Livent has a market capitalization of $1.04 billion and generates $388.40 million in revenue each year. The company earns $50.20 million in net income (profit) each year or $0.42 on an earnings per share basis.

What is Livent's official website?

The official website for Livent is www.livent.com.

How can I contact Livent?

Livent's mailing address is 2929 WALNUT STREET, PHILADELPHIA PA, 19104. The company can be reached via phone at 215-299-6000 or via email at [email protected]

This page was last updated on 8/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.